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ABSTRACT
Objectives To explore the experiences and perceptions 
of trial participants and healthcare professionals in the 
UK Frozen Shoulder Trial (UK FROST), a multicentre 
randomised controlled trial that compared manipulation 
under anaesthesia (MUA), arthroscopic capsular release 
(ACR) with a 12- week early structured physiotherapy 
programme (ESP) in people with unilateral frozen shoulder 
referred to secondary care.
Design Nested qualitative study with semistructured 
interviews. We used constant comparison method to 
develop our themes.
Setting This qualitative study was nested within the UK 
FROST.
Participants 44 trial participants (ESP: 14; MUA: 15; ACR: 
15), and 8 surgeons and 8 physiotherapists who delivered 
the treatments in the trial.
Results Trial participants found UK FROST treatments 
acceptable and satisfactory in terms of content, 
delivery and treatment benefits. Participants in all arms 
experienced improvements in pain, shoulder movements, 
and function. Participants said they would choose the 
same treatment that they received in the trial.
Surgeons and physiotherapists felt that the content and 
delivery of UK FROST treatments was not significantly 
different to their routine practice except for the additional 
number of physiotherapy sessions offered in the trial. 
They had mixed feelings about the effectiveness of UK 
FROST treatments. Both stressed the value of including 
hydrodilatation as a comparator of other treatment options. 
Physiotherapists raised concerns about the capacity to 
deliver the number of UK FROST physiotherapy sessions in 
routine clinical settings.
Shared perceptions of trial participants, surgeons and 
physiotherapists were: (1) Pain relief and return of 
shoulder movements and function are important outcomes 
and (2) Adherence to exercises leads to better outcomes.
Conclusion In general, our findings indicated that 
trial participants, and surgeons and physiotherapists 
who delivered the treatments had positive experiences 
and perceptions in the UK FROST. Early qualitative 
investigations to explore the feasibility of delivering 
treatments in real- world settings are suggested in future 
trials in the frozen shoulder.
Trial registration number International 
Standard Randomised Controlled Trial Register, ID: 
ISRCTN48804508. Registered on 25 July 2014; Results
INTRODUCTION
Frozen shoulder or adhesive capsulitis is 
a chronic shoulder condition commonly 
affecting people aged between 50 and 60 
years.1 Women are affected four times than 
men,2 while the prevalence rate is around 
20% in people with diabetes.2 Frozen 
shoulder is characterised by three clinical 
stages that often overlap3 4: (1) a painful stage 
(3–8 months), (2) a stiffness (frozen) stage 
(4–12 months) with progressive loss of active 
and passive shoulder movements and (3) a 
thawing stage (12–42 months) with gradual 
recovery of movements in most people.2
Strengths and limitations of this study
 ► Interviews were conducted and analysed by a re-
searcher who was not involved in the UK Frozen 
Shoulder Trial (UK FROST).
 ► Interview codes and themes were reviewed by an 
experienced researcher to ensure rigour of analysis 
and interpretation of data.
 ► Interviews were conducted with trial participants 
and healthcare professionals who participated in the 
UK FROST. Therefore, the findings may not be trans-
ferable outside this context.
 ► Ninety- three per cent of the interviews were 
telephone based. It is uncertain if interviewees 
would have expressed differently in face- to- face 
interviews.
 ► Those who did not participate in the interviews may 
have had different experiences.
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Frozen shoulder is managed by non- surgical or surgical 
treatments.3 5–9 However, there is no high- quality evidence 
to recommend one treatment over another.3 The UK 
Frozen Shoulder Trial (UK FROST) is a multicentre, prag-
matic randomised controlled trial in adults with frozen 
shoulder.10 It evaluated the clinical and cost- effectiveness 
of two common surgical treatments: manipulation under 
anaesthesia (MUA) and arthroscopic capsular release 
(ACR) both followed by up to 12 weeks of postprocedural 
physiotherapy (PPP), with a 12- week early structured 
physiotherapy (ESP) programme that included an intra- 
articular steroid injection. Detailed descriptions of the 
trial treatments, including the specifically developed ESP 
and PPP pathways are available.10
The qualitative literature on frozen shoulder is 
limited.11 12 There are no trials in frozen shoulder with 
an embedded qualitative component that explored the 
perspectives of trial participants (patients with frozen 
shoulder) and healthcare professionals who delivered 
the trial treatments. Therefore, we proposed a nested 
qualitative study within the UK FROST to explore the 
experiences and perceptions of trial participants who 
received UK FROST treatments, and healthcare profes-
sionals (surgeons and physiotherapists) who delivered 
those treatments.
METHODS
A qualitative and constructivist approach13 was adopted 
to understand the experiences and perceptions of trial 
participants and healthcare professionals in the UK 
FROST.
The primary author (CS) is a physiotherapy researcher 
trained in qualitative methods and not involved in the 
delivery of UK FROST treatments and outcome measure-
ment. CS conducted all the interviews and led the analysis. 
FT is an experienced qualitative researcher, anthropolo-
gist and physiotherapist, also not involved in delivery of 
care or outcome measurement. FT played a collaborative 
role in analysis.
Participants who took part in the main trial had primary 
unilateral frozen shoulder, identified through a restric-
tion of passive external rotation on clinical examination. 
They were randomly assigned to MUA, ACR or ESP treat-
ment arms in the ratio of 2:2:1. A purposive sample of trial 
participants was recruited from those who had agreed to 
be contacted by the trial team for interviews at approx-
imately 12 months postrandomisation, which coincided 
with the primary endpoint of the trial and completion of 
UK FROST treatments.10 We proposed to recruit up to 
45 trial participants. As gender and diabetes are likely to 
have an impact on the treatment outcomes,2 10 we also 
planned to include an equal number of men and women, 
and those with and without diabetes.
We also planned to recruit a purposive sample of up to 
15 surgeons and physiotherapists who delivered the treat-
ments in the trial and agreed to take part in the interviews.
The study information sheet and consent form were 
posted to potential trial participants and emailed to 
surgeons and physiotherapists. Two postal or email 
reminders were sent to those who did not respond within 
4 weeks of invitation. Once signed consent was received 
via post or email, CS contacted potential participants via 
telephone to coordinate an interview appointment with 
them.
Separate semistructured interview guides with open- 
ended questions were used for trial participants and 
health professionals. Given the geographical spread of 
those participated, interviews were conducted face to face 
or via telephone. Interviews were audiorecorded using a 
digital recorder, anonymised and transcribed verbatim by 
a professional transcription agency.
The interviews were analysed using constant compara-
tive method13 14 to develop categories and themes with a 
shared essence. The QSR International’s NVivo V.11 soft-
ware15 was used to organise and assist analysis of the data. 
The analysis was stopped at the point where additional 
data no longer contributed to the understanding of the 
themes. To enhance credibility of the findings, codes 
and themes were reviewed by an experienced qualitative 
researcher (FT). The Standards for Reporting Qualita-
tive Research (SRQR) guidelines were used to report the 
study.16
Patient and public involvement
The patient interview guide was developed following 
discussions with patients with frozen shoulder, research 
team, a physiotherapist and surgeon with expertise in this 
area, and reviewing the literature.
RESULTS
Sixty interviews (participants: 44; surgeons: 8 and phys-
iotherapists: 8) were completed between August 2016 
and January 2018. Most interviews (56/60, 93%) were 
conducted via telephone. Four interviews were held at the 
clinic offices of surgeons and physiotherapists. Though 
constant comparison was used to analyse data, a formal 
theory was not developed.
Interviews with trial participants
A flow diagram showing the number of patients invited, 
excluded and participated in the interviews is presented 
in figure 1. Participant characteristics are presented in 
table 1. Apart from two participants, all other participants 
received their allocated treatment.
Five themes were identified. The themes were not 
different between men and women; and between those 
with and without diabetes.
Experiences and perceptions of participating in the UK FROST
In general, trial participants had positive experiences 
in participating in UK FROST. They described altruistic 
and personal reasons for taking part in the trial. They 
were concerned about their upper limb disability from 
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frozen shoulder and were keen on getting it sorted in 
UK FROST. There was also an overall sense that the trial 
questionnaires were relevant, simple and straightforward 
to complete.
Because I’m all in favour, if you can do something 
to help other people not go through the misery 
that you’ve been through, and gone through, then I 
would do it. (ESP)
Trial participants felt that their treatment packages were 
well coordinated and did not require any modification. 
The surgical procedures were clearly explained and phys-
iotherapists who delivered ESP and PPP were supportive 
and helpful. Participants also liked to see the same physi-
otherapist for developing good connections and rapport 
throughout the study period. However, some ESP and 
ACR arm participants felt that the exercises were time 
consuming and found it difficult to fit into their daily life. 
Some said that they would have liked more information 
about continuing exercises after the trial and exercising 
when in pain.
Operation, I believe obviously went fantastic, went 
really well. It was just a case of waking up, recovery. 
(ACR)
Well personally I found it quite difficult to make 
sure I had them that many times in the day. I’m not 
too sure how somebody working or having a family 
could actually manage to fit it in because as I say, by 
the time going towards the middle to the end of the 
programme… (ESP)
Acceptability: treatment satisfaction and improved outcomes
All UK FROST treatments were found to be acceptable, 
satisfactory and beneficial. Except for two participants in 
the ESP arm, others were satisfied with the UK FROST 
treatments they received. Of these two exceptions, one 
did not improve after physiotherapy in the trial and the 
other was not satisfied when the exercise sessions were 
supervised by an unfamiliar physiotherapist.
I’m absolutely delighted with the treatment that I was 
given. I feel as though it did everything that I wanted 
it to do and expected it to do. (ESP)
Very satisfied. I have no complaints at all (ACR).
Participants considered pain relief and return of 
shoulder movements and function as important treat-
ment outcomes. Participants in all arms experienced 
improvements in pain, movements and function. In spite 
of achieving pain relief and improved function, some 
participants said they experienced mild and occasional 
pain and restrictions during certain end- range activities. 
However, this did not impact their daily functioning.
Pain
Trial participants experienced a substantial reduction 
in pain in all treatment arms. The ESP arm participants 
said that the steroid injections reduced pain and allowed 
them to start physiotherapy.
When I went to the surgeon I was injected into my 
shoulder and the pain down my arm that more or less 
went straightaway. (ESP)
So at the beginning I said the pain was ten and now 
after all my physios, I’d say it was, I’d say it was about 
two now. (MUA)
I mean the pain in the beginning was just horren-
dous, it was really, really sore, really painful but after 
I’d had the physiotherapy, it was… I’ve got no pain at 
all now. (ACR)
Movements
Trial participants described how the physiotherapy 
sessions (ESP and PPP) had helped to improve their 
shoulder movements.
I could tell initially straightaway that my movement 
was starting to come, within a few days I could tell 
a difference of doing the exercises and as the weeks 
went on, it was just got better and better and by the 
time the twelve weeks was up, I virtually had full move-
ments with no pain or anything, it was brilliant! (ESP)
Figure 1 Interviews with trial participants. ACR, 
arthroscopic capsular release; ESP, early structured 
physiotherapy; MUA, manipulation under anaesthesia.









ESP 5 9 58 (51–63.5) 3 11
MUA 8 7 55 (53–57.5) 5 10
ACR 7 8 59 (53–69) 5 10
ACR, arthroscopic capsular release; ESP, early structured 
physiotherapy; IQR, Interquartile Range; MUA, manipulation 
under anaesthesia; UK FROST, UK Frozen Shoulder Trial.
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After a few days I was doing my exercises and I was 
quite surprised already how much movement I had 
back and then it was regular physio appointments up 
at the hospital just to keep moving things around and 
that went really well…the physiotherapy was actually 
really, really beneficial. (MUA)
In the ACR arm, improvement in movements was 
thought to be quicker than participants had expected. 
Some experienced improvements as early as 1–2 weeks of 
physiotherapy after surgery.
I felt that the physiotherapy I received was marvellous 
and improved the range of movements or showed me 
how to keep that range of movements much quicker 
than they did on the right- hand side, so I felt that ev-
erything went along fine, and I’ve got no complaints 
at all, none. (ACR)
It is almost like you have had a quick fix to fix your 
shoulder then you move on and I think personally 
for me because the surgery went very well and almost 
after a couple of weeks I was back to normal. (ACR)
Function
Trial participants in all treatment arms described how 
their ability to do routine activities improved.
I can lift my arm above my head now, you know? I 
can carry stuff, and I can lift it above my waist, and I 
can actually go swimming, you know? I can swim now. 
(ESP)
My little everyday things have come back; I have come 
back, yes. (MUA)
I can do everything—there’s nothing that I can’t do; 
I can wash my back, I can put my bra on, fasten it 
at the back, I can fasten my skirt at the side and the 
back now, there’s nothing I can’t do before I had the 
frozen shoulder everything I could do then I can now 
do again. (ACR)
Adherence to exercises
Trial participants described that ESP and PPP were diffi-
cult to begin with, but became easier on subsequent 
sessions.
It (Physiotherapy) was agony but from every session 
there was slight improvement, so for every kind, every 
session I had, I had more movement and less pain, 
so it got to a point where some days I would go down 
and I had no pain at all. (ESP)
However, participants were aware of the benefits of 
exercises and persevered with their home exercises 
during the study period.
It was uncomfortable but I tried really hard with them 
to be honest because it was so awful when I couldn’t 
use my arm that I knew that the only way to help it was 
to do them as much as I could. (MUA)
Several participants said they did not continue their 
home exercises after the trial because they felt they 
had regained adequate shoulder function. Instead, they 
maintained their shoulder mobility by being functionally 
active. A few participants occasionally did some shoulder 
stretches.
I’m working with my shoulder all the time so I’m not 
doing the exercises that the hospital gave me, be-
cause I’m working my, I’m swimming, I’m doing…I 
go on long walks, I take the dog out and what have 
you, so I’m using my arm. (ESP)
Personal treatment preferences
Trial participants had mixed treatment preferences before 
the trial. Some considered physiotherapy to be ineffec-
tive, while a few wanted to avoid the risks of surgery. Some 
preferred the less invasive MUA while some thought ACR 
as the final solution. Some didn’t have any preference at 
all.
I’m not really too sure why I wouldn’t choose phys-
iotherapy. I just think surgery seems a more final 
option. Physiotherapy, it might work, it may help, it 
may not. But to me, if I was given surgery, the surgery 
would work. I had more faith in the surgery working 
than the physiotherapy itself. (ACR)
Well I didn’t want to go to surgery or anything like 
that, so I just had the needle in my shoulder. I don’t 
think I’d have wanted to go surgery at my age (ESP)
Despite preferences at the outset, at the end of the trial, 
there was a sense that participants would choose the same 
treatment they received in the UK FROST. In retrospect, 
some participants in ESP and MUA said that they would 
choose surgery as a permanent and time- saving solution 
for their shoulder problem.
Oh no I would have the same treatment. As I say I was 
only there for ten weeks and I mean, on my eleventh 
week I was still hell of a lot better. (ESP)
Interviews with surgeons and physiotherapists
A flow diagram showing the number of health profes-
sionals invited, excluded and participated in the inter-
views is presented in figure 2. The characteristics of 
surgeons and physiotherapists are presented in table 2.
Four themes were identified.
Experiences and perceptions of delivering UK FROST treatments
In general, surgeons and physiotherapists had positive 
experiences in delivering the trial treatments. Surgeons 
described how the surgical treatments were no different 
from their usual practice. They described how trial partic-
ipants who received MUA or ACR were usually seen by 
specialised physiotherapists for advice and PPP at the 
follow- up stage. Some said there were no reports of 
complications or side effects due to surgery, while some 
said that a few patients did not respond well to ESP.
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Surgeon 1: Technically there was no difference, I 
wouldn’t do anything different.
Surgeon 6: In the physiotherapy group, there have 
been a couple of patients who have not responded 
very well to surgery, very well to the treatment, to the 
physiotherapy treatment and we have just carried on 
and they've taken a bit longer.
Physiotherapists felt that the UK FROST physiotherapy 
programmes and the exercise booklet gave more flexi-
bility in choosing the exercises than they would usually 
have in their routine practice. The only difference was the 
increased number of sessions offered in the trial. Surgical 
soreness was a commonly seen postoperative issue in ACR 
and MUA participants. However, it was quick to resolve 
with PPP compared with those who received ESP. There 
were a few suggestions from physiotherapists to improve 
the UK FROST exercise intervention. For example, one 
physiotherapist felt the exercises could have been stand-
ardised better. Two others suggested either spreading the 
12 weekly sessions over 6 months or doing group sessions.
Physiotherapist 1: I think the interventions that were 
on the booklet were what I would use generally. There 
was always an option there for me to tick off what I 
would do so I was in agreement with the options that 
were there and in agreement with the options that 
they actually, didn’t want you to use.
Physiotherapist 5: I think group sessions would be re-
ally useful because patients get a lot from each other, 
and having experience group sessions with other cli-
ents with different pathologies, you know, they find 
that really reassuring…
Physiotherapists also commented on the feasibility of 
delivering the UK FROST physiotherapy programmes 
within the National Health Service (NHS) settings. There 
was a sense that it would be difficult to deliver the number 
of UK FROST physiotherapy sessions in routine practice.
Physiotherapist 4: … they (Trial participants) were 
seen with the 24 hours’ post- surgery and they had 
twelve sessions which is a luxury because in our Trust, 
that is never, not going to happen and that never 
used to happen.
Expectations and preferences about UK FROST treatments
Although health professionals said that they maintained 
equipoise, some described mixed expectations regarding 
UK FROST treatments. For example, some felt that ESP 
would not be as effective as surgery.
Surgeon 7: My expectation is that physio won’t work. 
My expectation is that the other two are probably 
Equivocal.
Some felt that ACR would perform better than ESP, 
while others felt that MUA would be comparable to ACR. 
There were also those who expected similar outcomes 
across arms.
Physiotherapist 6: I’m expecting the MUAs to be sur-
prisingly better than I would expect. I think the ar-
throlysis do great anyway and the physio is an unfair 
one.
Surgeons and physiotherapists suggested hydrodilata-
tion would be an easy to use, less invasive and inexpensive 
treatment and an appropriate alternative to combat NHS 
surgery waiting lists. They felt hydrodilatation should have 
been included as a potential comparator in UK FROST.
Surgeon 5: I’d definitely have a hydro- dilatation 
group because part of your trial is trying to work out if 
the cheaper operation is better than the more expen-
sive operation and hydro- dilatations probably gained 
quite popularity since we started the trial design and 
it reflects current practice.
Physiotherapist 6: It needs hydro- dilatation in it. I 
personally think it gets really good results on a big 
bulk of trial participants and it’s a wasted opportunity 
to have done this study and not have that as one of 
the arms.
Factors that influence treatment outcomes
Similar to trial participants, surgeons and physiotherapists 
also felt that reduced pain, improved movement and func-
tion were important treatment outcomes. They consid-
ered that patient engagement and positive treatment 
Figure 2 Interviews with surgeons and physiotherapists.
Table 2 Characteristics of the surgeons and 
physiotherapists interviewed
Gender
Years of experience 
in treating shoulder 
conditions
Male Female Median (IQR) years
Surgeons 7 1 11 (7–16.25)
Physiotherapists - 8 13.5 (12–15.75)
IQR, Interquartile Range.
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expectations would contribute to better outcomes, while 
diabetes would have a negative impact on prognosis.
Physiotherapist 5: I think the expectations and belief 
is probably the most noticeable factor that affects 
people’s outcome; if they believe something is the 
right thing, the best thing for them, they seem to do 
well.
Surgeon 8: …I’ve seen plenty of them of male 
diabetics that say, ‘Well, I’ve been stiff for 3 years,’ or 
two and a half years, that’s not uncommon
Perceptions of trial participants’ experience in the trial
Surgeons and physiotherapists described that some 
patients declined to take part in the UK FROST because 
they had previous physiotherapy that did not work and 
hence wanted to avoid randomisation into the ESP.
Surgeon 8: Many of them they say, ‘Look, I would love 
to contribute to the greater good and be involved in 
clinical trials, but I’ve come to the point that I will 
not consent for physiotherapy if I was randomised to 
that…
They also described that participants came with fixed 
ideas of what treatment they wanted in the trial.
Physiotherapist 8: So, we saw a lot of frozen shoulders 
coming in, but a lot of them had fixed ideas of what 
treatment they wanted. They didn’t want surgery yet, 
or they didn’t want to take time off work was the oth-
er one, but less so. The standout one was they didn’t 
want an operation, or they wanted to try physiothera-
py and injection and then they would opt for surgery. 
They wanted it to be continuum like that, not a one 
or the other.
However, surgeons and physiotherapists felt that trial 
participants found all the treatment arms acceptable 
once they were in the trial.
Surgeon 6: Once they had consented to be part of the 
study, and they had no problems because they were 
equally welcome on what treatment they would get… 
all those who once we enrolled them on to the study, 
were okay with that.
Physiotherapists described how trial participants were 
surprised with the number of PPP sessions they received.
Physiotherapist 1: I think they’ve been grateful and 
surprised at the amount of treatment (PPP) that they 
are allowed to have following the procedure.
DISCUSSION
Principal findings
We interviewed the trial participants and healthcare 
professionals (surgeons and physiotherapists) to under-
stand their experiences and perceptions of participating 
in the UK FROST. Our key findings were: Trial participants 
reported improved treatment outcomes and satisfaction 
with the trial treatments. All those interviewed had their 
personal treatment preferences and expectations about 
UK FROST treatments. Exercise adherence was consid-
ered important for better treatment outcomes.
Pain relief and return of shoulder movements and function are 
important treatment outcomes
Trial participants and healthcare professionals agreed 
that pain relief and improvement in function and move-
ment were important treatment outcomes. Their prior-
ities are similar to the results of a previous survey in 225 
healthcare professionals in the UK17 and three systematic 
reviews on shoulder outcomes.18–20
Adherence to prescribed exercises is important for better 
outcomes
Trial participants and healthcare professionals described 
continued patient engagement with the prescribed exer-
cise as important for better outcomes.21–23 During the 
trial, UK FROST participants were motivated by treat-
ment benefits24 and did their home exercises regularly. 
They were also self- determined24 to persevere through 
the pain associated with exercise. However, after the 
trial, participants did not continue exercising because 
they thought they achieved enough movement to allow 
adequate daily function. Therefore, they prioritised 
continuing their daily functional activities and ignored 
the occasional pain and mild restrictions during certain 
end- range movements. These findings are in line with a 
previous study which conceptualised participants’ views 
on ‘ideal’ (no symptoms at all) and ‘adequate’ (return to 
function with residual deficits) recovery from musculo-
skeletal complaints.25
Trial participants and healthcare professionals had their 
personal preferences/expectations about UK FROST 
treatments
It is natural and inevitable that patients have their own 
treatment preferences. It is well known that personal 
preferences have a psychological therapeutic impact 
on treatment outcomes.26 27 If participants get their 
preferred treatment in a trial, they are more likely to 
stay motivated, comply better and respond well. Partici-
pants who do not receive their preferred treatment might 
lack motivation and become less engaged. Though our 
findings indicate that trial participants had mixed pref-
erences before participation, all UK FROST treatments 
were well- received at the end.
Our interview findings also indicated mixed expecta-
tions and preferences among UK FROST surgeons and 
physiotherapists, mainly based on their clinical experi-
ence.28–30 Expert surgical and physiotherapy experience 
require years of skill building, training and repeated prac-
tice. It would be highly unlikely if experts did not acquire 
personal expectations or preferences. Some might argue 
that this is integral to developing expertise. This has 
significant implications in trials as it has an important 
7Srikesavan C, et al. BMJ Open 2021;11:e040829. doi:10.1136/bmjopen-2020-040829
Open access
impact on equipoise. Our findings confirm that personal 
treatment expectations do exist among healthcare profes-
sionals, especially when treatment decisions are mainly 
expertise- based rather than evidence- based in treatment 
decision making.
Surgeons and physiotherapists also perceived hydrodi-
latation as easy to administer, less invasive and a cost- 
effective treatment for frozen shoulder instead of surgery. 
These findings resonate with its growing popularity and 
usage in clinical practice,31 in spite of a lack of sufficient 
evidence on efficacy and safety.32 33
Strengths and limitations
Interviews were conducted by a researcher not involved 
in UK FROST and by using open- ended questions that 
allowed interviewees to express their opinions freely. The 
interview codes and themes were reviewed by an experi-
enced qualitative researcher to ensure rigour of analysis 
and interpretation of data. We also discussed our prelim-
inary findings with a team of physiotherapists who treat 
people with frozen shoulder and the UK FROST team to 
produce our final themes.’
This study has some limitations. Interviews were 
conducted with trial participants and healthcare profes-
sionals who participated in the UK FROST. Therefore, 
the findings may not be transferable outside this context. 
Second, only two trial participants who did not receive 
their allocated treatments took part. This could have 
influenced their predominantly positive experiences with 
the trial treatments. Third, 93% of the interviews were 
conducted via telephone. Therefore, we are uncertain if 
interviewees would have expressed differently in face- to- 
face interviews. Lastly, those who did not participate in 
the interviews may have had different experiences.
Implications for clinical practice
All UK FROST treatments were perceived as acceptable, 
beneficial, and satisfactory. The benefits and anticipated 
risks of these treatments must be clearly communicated 
to patients during shared treatment decision making.
Implications for future research
1. Trial participants and healthcare professionals have 
preferences for treatments. Future studies should aim 
to understand how these preferences may influence 
trial results.
2. Implementation of UK FROST physiotherapy pro-
grammes within different NHS settings may be chal-
lenging. Pilot implementation studies to identify 
scaling- up strategies would be useful.
3. More large- scale and high- quality randomised con-
trolled trials to ensure clinical effectiveness and safety 
of hydrodilatation are required to guide evidence- based 
practice.
CONCLUSION
This qualitative study has provided a fuller understanding 
of the perspectives of UK FROST trial participants and 
healthcare professionals. Future trial designs would 
usefully consider including qualitative research as part of 
intervention development to ensure feasibility of deliv-
ering treatments within the NHS and to guide imple-
mentation beyond the trial. Evaluation of hydrodilatation 
compared with other treatment options is favoured 
by healthcare professionals. A prognostic tool to assist 
timely advice and treatment for people at risk of poorer 
outcomes would be helpful.
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